tiprankstipranks
Corcept Therapeutics Inc. (GB:0I3Q)
LSE:0I3Q

Corcept Therapeutics (0I3Q) Income Statement

0 Followers

Corcept Therapeutics Income Statement

Last quarter (Q4 2023), Corcept Therapeutics's total revenue was $135.41M, an increase of 31.39% from the same quarter last year. In Q4, Corcept Therapeutics's net income was $30.99M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 482.38M$ 482.38M$ 401.86M$ 365.98M$ 353.87M$ 306.49M
Cost of Revenue
$ 6.48M$ 6.48M$ 5.38M$ -5.28M$ 5.58M$ 5.50M
Gross Profit
$ 475.89M$ 475.89M$ 396.47M$ 360.70M$ 348.29M$ 300.98M
Operating Expense
$ 368.61M$ 368.61M$ 283.84M$ 236.22M$ 220.09M$ 189.38M
Operating Income
$ 107.28M$ 107.28M$ 112.63M$ 124.48M$ 128.20M$ 111.61M
Net Non Operating Interest Income Expense
$ 3.58M--$ 529.00K$ 3.40M$ 5.07M
Other Income Expense
$ -14.41M$ -17.27M$ -39.21M$ -31.38M--
Pretax Income
$ 124.56M$ 124.56M$ 116.19M$ 125.01M$ 131.60M$ 116.68M
Tax Provision
$ 18.42M$ 18.42M$ 14.77M$ 12.49M$ 25.59M$ 22.50M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 121.16M$ 105.50M$ 101.29M$ 112.51M$ 106.01M$ 94.18M
Basic EPS
$ 1.04$ 1.02$ 0.95$ 0.97$ 0.92$ 0.82
Diluted EPS
$ 0.95$ 0.94$ 0.87$ 0.89$ 0.85$ 0.77
Basic Average Shares
$ 414.24M$ 103.56M$ 106.79M$ 115.65M$ 115.41M$ 114.35M
Diluted Average Shares
$ 446.97M$ 111.74M$ 115.97M$ 125.96M$ 124.19M$ 122.57M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----$ 1.26$ 0.82
Reported Normalized Diluted E P S
----$ 1.17$ 0.77
Rent Expense Supplemental
------
Total Expenses
$ 375.09M$ 375.09M$ 289.22M$ 230.94M$ 225.67M$ 194.88M
Net Income From Continuing And Discontinued Operation
$ 106.14M$ 106.14M$ 101.42M$ 112.51M$ 106.01M$ 94.18M
Normalized Income
$ 38.67M$ 53.23M$ 38.58M-$ 106.01M$ 94.18M
Interest Expense
------
EBIT
$ 124.56M$ 124.56M$ 116.19M$ 125.01M$ 128.20M$ 111.61M
EBITDA
$ 117.79M$ 117.79M$ 119.16M$ 128.07M$ 130.44M$ 113.78M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis